Navigation Links
New Corporate Website Launched - Focus on Life Scientists, Flow Cytometrists, & Clinicians
Date:10/11/2007

HAYWARD, Calif., Oct. 11 /PRNewswire/ -- Guava Technologies today launched a new corporate website with an infrastructure focused around its main audiences: Life Scientists, Flow Cytometrists, and Clinicians.

With flow cytometry being an essential tool for cell analysis, Guava Technologies is dedicated to finding innovative ways to make the technology as practical as possible for all life scientists and clinicians who work with cells. This dedication is obvious from the audience-centric organization of the new site, where the main choices on the home page for further investigation are targeted to the unique needs of the company's main markets: Life Science Research (i.e., pharma/biotech, academia/government, clinical research), Flow Cytometry, and Clinical Diagnostics.

While the website does offer traditional navigation, those links are secondary. The site is obviously built around the company's desire to serve its key market segments and stakeholders. According to Lawrence Bruder, CEO, the audience-centric organization was the obvious choice from the beginning: "Those individuals are the reason we are in business; the reason our employees come to work every day," said Mr. Bruder, "so given the importance of our website as a vehicle for two-way communication with them, it just made sense to focus it on their needs."

Guava Technologies encourages everyone interested in flow cytometry or the company to visit the site at http://www.guavatechnologies.com, and to let the company know what it can do to further improve the site based on their needs and interests.

Guava Technologies is a private biotechnology and medical device company. In 2001, it introduced the first commercial benchtop microcapillary flow cytometer with easy-to-use, assay-specific reagents and software. Since then, it has introduced numerous new systems and assays, always focusing on making flow cytometry more practical for life scientists and clinicians. Guava Systems do not require sheath fluid so accommodate smaller sample volumes, generate less waste, have lower daily operate costs, and are easier to set-up and maintain than traditional flow cytometers. And, all Guava Systems perform direct, absolute cell counts without reference beads. True to the company's goal, virtually any scientist or clinician can learn to operate a Guava System in less than one day.


'/>"/>
SOURCE Guava Technologies
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Selecting siRNA Sequences to Incorporate into the pSilencer Vectors
2. Pre-eminent, web-based companies owe success to corporate venturing
3. Corporate Social Responsibility - Burden, sham, or golden opportunity?
4. Corporate venturing can nurture software success
5. Enrons dilemma: A corporate governance nightmare
6. Getting beyond the vortex of corporate mediocrity
7. Corporate control begins with a strong board
8. Directors more assertive in corporate governance
9. The black hole of corporate branding
10. Corporate Americas hidden deficit
11. Business professor launches corporate reporting study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2020)... ... February 05, 2020 , ... Rare Disease Day® , held the ... Organization for Rare Disorders (NORD), to raise awareness amongst the general public and decision-makers ... Balancing Act’s “Behind The Mystery” rare disease series will be shining the ...
(Date:1/28/2020)... ... January 28, 2020 , ... Today, Salimetrics announced ... The new Salivary Total Human IgG Assay Kit exemplifies Salimetrics’ 20+ ... saliva, researchers can extend the accuracy and ease of use of salivary bioscience ...
(Date:1/24/2020)... MONTEREY, Calif. (PRWEB) , ... January 24, 2020 ... ... the launch of their RedySmart™ mass flow meters and controllers ideal ... as an ideal upgrade to antiquated rotameters. These thermal instruments employ high-precision ...
(Date:1/22/2020)... ... 2020 , ... QCDx , a private biotech company that has developed ... announced the sale of the proprietary RareScope™ instrument to the Carole and Ray Neag ... cancer research. , “The RareScope can detect and isolate intact and live Circulating Tumor ...
Breaking Biology Technology:
(Date:1/24/2020)... ... January 24, 2020 , ... Shoreline Biome , a microbiome research ... announced that the company will debut a novel new DNA isolation kit at the ... product, Shoreline Biome's Rapid Prep kit, is a fast and easy-to-use kit designed for ...
(Date:1/23/2020)... ... January 23, 2020 , ... ... mature red blood cells from stem cells. The red blood cells are ... under strictly controlled conditions, for transfusion therapy and replaces the need for a ...
(Date:1/22/2020)... ... January 21, 2020 , ... Astro Pak’s president Ken ... Development Department. The move, which is part of the company’s structural reorganization, was ... company’s Senior Vice President where he oversaw its Cleanroom Division as well as ...
Breaking Biology News(10 mins):